Title:
ORALLY DISINTEGRATING TABLET INCLUDING DIAMINE DERIVATIVE
Document Type and Number:
WIPO Patent Application WO/2018/101373
Kind Code:
A1
Abstract:
Provided is an orally disintegrating tablet containing edoxaban, a pharmacologically acceptable salt thereof, or a solvate thereof. The orally disintegrating tablet contains: (A) edoxaban, a pharmacologically acceptable salt thereof, or a solvate thereof; (B) an organic acid; (C) a water-soluble polymer, the content of which is 0.1-2.0 wt% with respect to the total weight of the tablet; and (D) a disintegrating agent.
Inventors:
KIKKAWA YOSHITO (JP)
KATO TAKAFUMI (JP)
KATO TAKAFUMI (JP)
Application Number:
PCT/JP2017/042930
Publication Date:
June 07, 2018
Filing Date:
November 30, 2017
Export Citation:
Assignee:
DAIICHI SANKYO CO LTD (JP)
International Classes:
A61K31/444; A61K9/20; A61K47/12; A61K47/18; A61K47/26; A61K47/32; A61K47/36; A61K47/38; A61P7/02
Domestic Patent References:
WO2013022059A1 | 2013-02-14 | |||
WO2013161823A1 | 2013-10-31 |
Foreign References:
CN102058889A | 2011-05-18 | |||
US20150110880A1 | 2015-04-23 | |||
JP5295506B2 | 2013-09-18 | |||
US9149532B2 | 2015-10-06 | |||
US9402907B2 | 2016-08-02 |
Other References:
See also references of EP 3549585A4
Attorney, Agent or Firm:
ISHIBASHI, Koki et al. (JP)
Download PDF:
Previous Patent: ADHESIVE COMPOSITION, ADHESIVE LAYER, AND ADHESIVE SHEET
Next Patent: TILTING VEHICLE
Next Patent: TILTING VEHICLE